09:47 AM EST - ESSA Pharma Inc. : Has granted incentive stock options to directors and officers, employees and consults of the Corporation to purchase up to an aggregate of 238,000 common shares in the capital of the Corporation. Such stock options will vest in 48 equal monthly instalments, with the first instalment vesting on the one-month anniversary of the grant date. The stock options are exercisable on or before February 8, 2029 at the price of $3.81 U.S. per Common share and are granted in accordance with the policies of the TSX Venture Exchange and the terms and conditions of the Corporation's stock option plan. ESSA Pharma Inc.
shares V.EPI are trading unchanged at $3.55.
